Commentary on “Genome‐wide meta‐analysis identifies novel susceptibility loci for autoimmune hepatitis type 1”
Victoria L. Mulcahy, George F. Mells – 1 May 2022
Soluble factors and suppressive monocytes can predict early development of sepsis in acute‐on‐chronic liver failure
Pushpa Yadav, Nirupama Trehanpati, Rakhi Maiwall, Rashi Sehgal, Ravinder Singh, Mojahidul Islam, Rakesh Kumar Jagdish, Rajan Vijayaraghavan, Deepanshu Maheshwari, Sadam Bhat, Pratibha Kale, Anupam Kumar, Sukriti Baweja, Guresh Kumar, Gayatri Ramakrishna, Shiv K. Sarin – 1 May 2022 – Patients with acute‐on‐chronic liver failure (ACLF) have a high probability of developing systemic inflammation and sepsis due to immune dysregulation.
Immunotherapy in HCC—No rush despite the hype
Bruno Sangro, Josepmaria Argemí – 30 April 2022
Letter to the editor: Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD
Yuan Qin, Anqi Li, Bilin Liu, Meng Gao, Guohua Gong – 30 April 2022
A new model for estimation of significant fibrosis in primary care. SAFE to use?
Hannes Hagström – 30 April 2022
Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis
Jun Zhou, Yongkun Sun, Wen Zhang, Jiajia Yuan, Zhi Peng, Wei Wang, Jifang Gong, Lin Yang, Yanshuo Cao, Hong Zhao, Chao Chen, Weifeng Wang, Lin Shen, Aiping Zhou – 30 April 2022
Clinical Assessment and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease
AASLD develops evidence-based practice guidelines and practice guidances which are updated regularly by a committee of hepatology experts and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care.
Liver Transplantation: Adult
AASLD develops evidence-based practice guidelines and practice guidances which are updated regularly by a multi-disciplinary panel of experts, including hepatologists, and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care.
Management of Autoimmune Hepatitis
AASLD develops evidence-based practice guidelines and practice guidances which are updated regularly by a multi-disciplinary panel of experts, including hepatologists, and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care.
Patient Guidelines
Patient guidelines are adaptations and patient-friendly summaries of published AASLD Guidances which are written specifically for patients to help them understand their liver disease. Clinicians may also provide these patient guidances to their patients as a resource during consultations.